[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4385 followers
Created: 2025-07-07 12:30:08 UTC

$DNLI Clinical Trials:

On July 7, 2025, Denali Therapeutics announced that the U.S. FDA accepted its Biologics License Application for tividenofusp alfa to treat Hunter syndrome, granting it Priority Review.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1942199453030776924/c:line.svg)

**Related Topics**
[sec](/topic/sec)
[$dnli](/topic/$dnli)

[Post Link](https://x.com/USCorpFilings/status/1942199453030776924)